What is Karyotyping?
Karyotyping is a laboratory test that analyzes all 23 pairs of chromosomes to detect large-scale chromosomal abnormalities. These may include missing or extra chromosomes, structural rearrangements such as translocations and inversions, and mosaicism.
It is performed on a blood sample and provides insight into whether an individual carries chromosomal variations that may impact fertility or the health of a future pregnancy.
Why is Karyotyping Important?
Many individuals with chromosomal abnormalities are asymptomatic and unaware of their status. However, they may carry balanced rearrangements that can increase the risk of embryo implantation failure, miscarriage, or the transmission of genetic conditions.
Karyotyping is recommended in the following situations:
- Two or more consecutive pregnancy losses
- Unexplained infertility or severe male factor infertility (e.g., azoospermia)
- Repeated IVF failure
- Family history of chromosomal disorders
- Prior birth of a child with a chromosomal condition
- Before using donor eggs or sperm (when clinically indicated)
What Can Karyotyping Detect?
Karyotyping helps identify large-scale chromosomal abnormalities that may impact fertility or embryo development. These include aneuploidy, where there are missing or extra chromosomes (such as in Turner syndrome or Klinefelter syndrome), as well as balanced and unbalanced translocations, where segments of chromosomes are rearranged. It can also reveal inversions, where a portion of a chromosome is flipped in orientation, and mosaicism, a condition in which different cells in the same individual have different chromosomal makeups.
It’s important to understand the difference between constitutional karyotyping, which examines the full set of chromosomes, and targeted chromosomal analysis (such as FISH or chromosomal microarray), which focuses on specific regions when a particular abnormality is suspected.
How the Test Works
Karyotyping is performed on a small blood sample. Once collected, the sample is sent to a specialized laboratory where white blood cells are cultured. The chromosomes are then stained, visualized under a microscope, and carefully analyzed for structural or numerical abnormalities. This process typically takes 2 to 3 weeks. After the results are ready, your Reproductive Endocrinologist or a genetic counselor will review the findings with you and explain what they mean in the context of your reproductive goals.
What if an Abnormality is Found?
If the analysis reveals a chromosomal abnormality, your doctor will explain the implications and guide you through available reproductive options. These may include proceeding with IVF using Preimplantation Genetic Testing (PGT-A or PGT-M) to select chromosomally normal embryos, using donor eggs or sperm if indicated, or planning for prenatal diagnostic testing such as chorionic villus sampling (CVS) or amniocentesis.
If mosaicism is suspected during embryo testing, the result is typically reported as putative or suggestive, as a single biopsy cannot fully represent the chromosomal status of the entire embryo.
When is Karyotyping NOT Enough?
While karyotyping is effective in identifying large chromosomal abnormalities, it cannot detect smaller genetic deletions or duplications. If more detailed analysis is needed, your doctor may recommend higher-resolution tests such as chromosomal microarray analysis (CMA) or whole exome sequencing (WES), which provide more precise insights into genetic variation.
Contact Personal Manager
Make an appointment or request more information. Leave your contact details and our team will get in touch with you!
Frequently Asked Questions (FAQs)
We know that fertility care often brings up many questions — and that every journey is different. Below you’ll find answers to some of the most common questions our patients ask.
Is karyotyping required before fertility treatment?
It depends on your medical history. Karyotyping is often recommended in cases of infertility, miscarriage, or known genetic risks.
Should both partners be tested?
Yes, in many cases both partners undergo testing—especially in cases of recurrent loss or suspected structural abnormalities.
How is karyotyping different from PGT-A?
Karyotyping analyzes the chromosomes of the parents through blood. PGT-A tests embryos during IVF to identify chromosomal abnormalities before transfer.
